InSilicoTrials, IBSA Group Partner to Expand AI Use in Drug Development

Press release · IBSA

IBSA Group and InSilicoTrials announce a multi-year collaboration integrating AI-driven simulation into IBSA's preclinical and clinical development pipelines.